DE SARRO, GIOVAMBATTISTA
 Distribuzione geografica
Continente #
NA - Nord America 19.022
AS - Asia 10.377
EU - Europa 4.962
SA - Sud America 2.111
Continente sconosciuto - Info sul continente non disponibili 555
AF - Africa 281
OC - Oceania 102
AN - Antartide 2
Totale 37.412
Nazione #
US - Stati Uniti d'America 18.213
SG - Singapore 4.383
CN - Cina 2.359
IT - Italia 2.081
BR - Brasile 1.619
IN - India 994
VN - Vietnam 955
GB - Regno Unito 660
DE - Germania 620
CA - Canada 580
BD - Bangladesh 457
SE - Svezia 441
HK - Hong Kong 390
FI - Finlandia 287
AR - Argentina 165
FR - Francia 152
MX - Messico 140
NL - Olanda 138
ID - Indonesia 119
JP - Giappone 97
AU - Australia 92
EC - Ecuador 85
ZA - Sudafrica 85
RU - Federazione Russa 84
CO - Colombia 75
PK - Pakistan 73
ES - Italia 71
IQ - Iraq 70
CL - Cile 65
AE - Emirati Arabi Uniti 64
TR - Turchia 62
UA - Ucraina 58
RO - Romania 56
EG - Egitto 49
PL - Polonia 48
UZ - Uzbekistan 44
KR - Corea 38
SA - Arabia Saudita 36
IR - Iran 33
VE - Venezuela 30
CZ - Repubblica Ceca 29
MA - Marocco 28
PY - Paraguay 28
PH - Filippine 27
IL - Israele 25
MY - Malesia 25
PE - Perù 25
CH - Svizzera 24
IE - Irlanda 24
AT - Austria 23
TN - Tunisia 20
PT - Portogallo 19
GR - Grecia 18
TW - Taiwan 18
EU - Europa 17
KE - Kenya 16
DO - Repubblica Dominicana 15
EE - Estonia 14
JM - Giamaica 14
JO - Giordania 14
NP - Nepal 14
UY - Uruguay 14
CR - Costa Rica 13
LT - Lituania 13
HN - Honduras 12
NO - Norvegia 12
RS - Serbia 12
SC - Seychelles 12
SK - Slovacchia (Repubblica Slovacca) 11
AZ - Azerbaigian 9
KZ - Kazakistan 9
NZ - Nuova Zelanda 9
TH - Thailandia 9
A2 - ???statistics.table.value.countryCode.A2??? 8
AL - Albania 8
BE - Belgio 8
DZ - Algeria 8
KW - Kuwait 8
MD - Moldavia 8
NG - Nigeria 8
NI - Nicaragua 8
HR - Croazia 7
MT - Malta 7
AO - Angola 6
SN - Senegal 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
BO - Bolivia 5
CI - Costa d'Avorio 5
CY - Cipro 5
ET - Etiopia 5
GT - Guatemala 5
LB - Libano 5
LK - Sri Lanka 5
UG - Uganda 5
BH - Bahrain 4
GH - Ghana 4
SI - Slovenia 4
Totale 36.804
Città #
San Jose 3.082
Dallas 2.066
Singapore 1.775
Chandler 1.671
Ashburn 1.296
Santa Clara 804
Council Bluffs 641
Milan 631
Bengaluru 616
Hefei 596
Princeton 542
Lawrence 519
Munich 475
Chicago 421
Beijing 412
London 400
Shenzhen 397
Hong Kong 358
Ho Chi Minh City 354
Ottawa 340
Wilmington 320
New York 212
Los Angeles 202
Catanzaro 190
Des Moines 185
Hanoi 185
São Paulo 167
Phoenix 155
Helsinki 138
Boardman 129
Turku 126
Rome 89
Brooklyn 87
Redwood City 82
The Dalles 77
Tokyo 76
Columbus 61
Boston 59
Mexico City 57
Montreal 57
Atlanta 55
Rio de Janeiro 55
San Francisco 55
Palermo 53
Shanghai 53
Norwalk 52
Orem 52
Haiphong 51
Naples 51
Toronto 51
Pune 49
Amsterdam 48
Buffalo 48
Johannesburg 45
Da Nang 44
Chennai 43
Tashkent 40
Guangzhou 39
Curitiba 38
Seattle 37
Jakarta 36
Guayaquil 35
Redmond 34
Denver 33
Florence 30
Melbourne 30
Porto Alegre 30
Santiago 30
Warsaw 30
Hải Dương 29
Brasília 28
West Jordan 28
Belo Horizonte 27
Campinas 27
Stockholm 27
Falls Church 26
Biên Hòa 25
Buenos Aires 25
Bogotá 24
Catania 24
Hyderabad 24
Charlotte 23
Istanbul 23
Mumbai 23
Manchester 22
Messina 22
Newark 22
San Nicola Manfredi 22
Augusta 21
Houston 21
Padova 21
Thái Bình 21
Bari 20
Quito 20
Bologna 19
Dhaka 19
Olomouc 19
Washington 19
Baghdad 18
Sydney 18
Totale 22.004
Nome #
1,4-benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 629
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 524
1-Aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents 513
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study 434
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 368
Adherence to therapy and adverse drug reactions: is there a link? 311
Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats 310
Adverse effects of atypical antipsychotics in the elderly: a review 308
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 262
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 191
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 190
Sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities 190
Neuropharmacology of depression in aging and age-related diseases 181
A Comprehensive Safety Evaluation of Trabectedin and Drug-Drug Interactions of Trabectedin-Based Combinations 178
Genetics of reflex seizures and epilepsies in humans and animals 174
Conventional and new antidepressant drugs in the elderly 163
A POSSIBLE DRUG-FOOD INTERACTION INDUCED GENERALISED URTICARIA IN A YOUNG WOMAN 162
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 160
High Prevalence of Achilles Tendon Enthesopathic Changes in Patients with Type 2 Diabetes Without Peripheral Neuropathy 152
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 147
Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice 141
Transient Receptor Potential Ankyrin 1 (TRPA1) mediates hydrogen sulfide-induced Ca2+ entry and nitric oxide production in human cerebrovascular endothelium. 139
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 138
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 137
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 136
Conventional and atypical antipsychotics in the elderly - A review 134
Topiramate potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 133
Venlafaxine-Propafenone interaction resulting in hallucinations and psychomotor agitation 133
Metformin and Autoimmunity: A "New Deal" of an Old Drug 132
25-Hydroxy Vitamin D Detection Using Different Analytic Methods in Patients with Migraine 131
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 128
Efficacy and safety of bevacizumab in glioblastomas 123
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 123
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 123
Chlorpromazine versus sleep deprivation in activation of EEG in adult-onset partial epilepsy. 120
Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice 119
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice) 115
Amino acid levels in some lethargic mouse brain areas before and after pentylenetetrazole kindling 114
Uno strano caso di deterioramento cognitivo: quando le interazioni farmaco-alimenti diventano fondamentali. 113
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 111
Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice 108
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 105
Neuroactive steroids and GABA(A) receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy 101
Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice 100
A review on antiepileptic drugs-dependent fatigue: Pathophysiological mechanisms and incidence 100
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 97
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 95
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy 95
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 94
Audiogenic epileptic DBA/2 mice strain as a model of genetic reflex seizures and SUDEP 93
Adverse reactions to fluoroquinolones. An overview on mechanistic aspects 93
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention 93
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 92
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 91
QUINOLONES POTENTIATE CEFAZOLIN-INDUCED SEIZURES IN DBA/2 MICE 91
9-cis Retinoic acid modulates myotrophin expression and its miR in physiological and pathophysiological cell models 91
A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment 90
Lamotrigine potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 90
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 90
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report 89
Melaena following use of the cholinesterase inhibitor rivastigmine 89
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 88
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 88
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 87
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 87
Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice 86
Cenobamate enhances the anticonvulsant effect of other antiseizure medications in the DBA/2 mouse model of reflex epilepsy 85
Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice 85
Apomorphine-induced neurodegeneration in Mongolian gerbil hippocampus 85
Influence of D-cycloserine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice 84
Determination of a potent non-competitive AMPA receptor antagonist in rat brain 84
3D pharmacophore models for 1,2,3,4-tetrahydroisoquinoline derivatives acting as anticonvulsant agents 84
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 83
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 83
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 82
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 82
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 81
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 81
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy 81
Vitamin D Serum Levels in Subjects Tested for SARS-CoV-2: What Are the Differences among Acute, Healed, and Negative COVID-19 Patients? A Multicenter Real-Practice Study 81
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 80
A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman 80
Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes 80
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 79
Data recorded in real life support the safety of nattokinase in patients with vascular diseases 79
Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents 78
7-nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 78
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 78
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 78
A case of adverse drug reaction induced by dispensing error 78
Adverse drug reactions related to drug administration in hospitalized patients. 78
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 78
Lithium in late-life mania: a systematic review 78
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 77
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 77
A fatal case of triple whammy in an elderly patient 76
Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient 76
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety. 75
Assessing Gender Differences in Neuropathic Pain Management: Findings from a Real-Life Clinical Cross-Sectional Observational Study 75
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 75
Totale 13.227
Categoria #
all - tutte 315.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 315.595


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.513 0 0 0 420 52 40 24 338 197 187 234 21
2022/20234.748 1.094 216 92 447 480 427 35 371 779 331 365 111
2023/20242.877 475 292 588 157 136 543 116 119 44 122 106 179
2024/20257.094 962 344 370 306 477 907 450 294 848 360 669 1.107
2025/202616.687 698 1.700 2.667 2.490 1.579 566 2.027 856 1.684 1.077 767 576
2026/20273.116 456 784 1.590 286 0 0 0 0 0 0 0 0
Totale 37.412